Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa

Journal:
Clinical Infectious Diseases
Published:
DOI:
10.1093/cid/ciag155
Affiliations:
6
Authors:
12
Go to article
Institutions Authors Share
Centre for the AIDS Programme of Research in South Africa (CAPRISA), South Africa
4.333333
 0.36
Discovery Limited, South Africa
4.000000
 0.33
London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom (UK)
1.500000
 0.13
University of Oxford, United Kingdom (UK)
1.000000
 0.08
University of KwaZulu-Natal (UKZN), South Africa
0.833333
 0.07
University of Cape Town (UCT), South Africa
0.333333
 0.03
Interested in Clinical Sciences?